{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:08:13Z","timestamp":1787238493678,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Rapid diagnosis and initiation of treatment are essential to improve outcomes for optic neuritis. However, many patients suspected of having optic neuritis may have different underlying conditions. This study aimed to investigate the spectrum of diseases in patients referred with suspected optic neuritis and to identify clinical factors associated with confirmed optic neuritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Retrospective cohort study<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study retrospectively reviewed 255 cases referred to Kobe University Hospital with suspected optic neuritis between January 2016 and June 2024. Cases were excluded if patients had a history of optic neuritis, encephalitis, or myelitis, were referred from non-ophthalmology departments, or resided outside Hyogo Prefecture. Logistic regression analysis was conducted to identify factors significantly associated with confirmed optic neuritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 206 eligible cases, 89 (43.2%) were confirmed to have optic neuritis. Other major diagnoses included anterior ischemic optic neuropathy (18.4%), space-occupying lesions such as intracranial tumors (11.7%), and retinal diseases or uveitis (10.2%). Logistic regression analysis revealed significant associations between confirmed optic neuritis and younger age, the presence of central scotoma, eye pain, decreased visual acuity, reduced critical flicker fusion frequency, and a shorter interval between symptom onset and consultation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although 43.2% of suspected cases were confirmed as optic neuritis, a substantial proportion was attributed to other conditions requiring distinct diagnostic and therapeutic approaches. These findings emphasize the critical role of multidisciplinary collaboration and evidence-based protocols in managing patients with acute visual impairment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10384-025-01286-0","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:10:35Z","timestamp":1761192635000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential diagnosis and clinical predictors in suspected optic neuritis"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1991-3232","authenticated-orcid":false,"given":"Sotaro","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamada-Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Matsumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sentaro","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp-2019-321653","volume":"91","author":"A Petzold","year":"2020","unstructured":"Petzold A, Braithwaite T, van Oosten BW, Balk L, Martinez-Lapiscina EH, Wheeler R, et al. Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence. J Neurol Neurosurg Psychiatry. 2020;91:9\u201314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1286_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326:581\u20138.","journal-title":"N Engl J Med"},{"key":"1286_CR3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","volume":"126","author":"H Ishikawa","year":"2019","unstructured":"Ishikawa H, Kezuka T, Shikishima K, Yamagami A, Hiraoka M, Chuman H, et al. Epidemiologic and clinical characteristics of optic neuritis in Japan. Ophthalmology. 2019;126:1385\u201398.","journal-title":"Ophthalmology"},{"key":"1286_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","volume":"220","author":"MB Hassan","year":"2020","unstructured":"Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, et al. Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies. Am J Ophthalmol. 2020;220:110\u20134.","journal-title":"Am J Ophthalmol"},{"key":"1286_CR5","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3389\/fneur.2020.00932","volume":"11","author":"T Akaishi","year":"2020","unstructured":"Akaishi T, Takeshita T, Himori N, Takahashi T, Misu T, Ogawa R, et al. Rapid administration of high-dose intravenous methylprednisolone improves visual outcomes after optic neuritis in patients with AQP4-IgG-positive NMOSD. Front Neurol. 2020;11:932.","journal-title":"Front Neurol"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"T K\u00fcmpfel","year":"2024","unstructured":"K\u00fcmpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, H\u00e4u\u00dfler V, et al. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)\u2014revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. J Neurol. 2024;271:141\u201376.","journal-title":"J Neurol"},{"key":"1286_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/WNO.0000000000000700","volume":"38","author":"L Horton","year":"2018","unstructured":"Horton L, Bennett JL. Acute management of optic neuritis: an evolving paradigm. J Neuroophthalmol. 2018;38:358\u201367.","journal-title":"J Neuroophthalmol"},{"key":"1286_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000495979","volume":"10","author":"S Mori","year":"2019","unstructured":"Mori S, Kurimoto T, Kawara K, Ueda K, Sakamoto M, Keshi Y, et al. The difficulty of diagnosing invasive aspergillosis initially manifesting as optic neuropathy. Case Rep Ophthalmol. 2019;10:11\u20138.","journal-title":"Case Rep Ophthalmol"},{"key":"1286_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaophthalmol.2017.5470","volume":"136","author":"L Stunkel","year":"2018","unstructured":"Stunkel L, Kung NH, Wilson B, McClelland CM, Van Stavern GP. Incidence and causes of overdiagnosis of optic neuritis. JAMA Ophthalmol. 2018;136:76\u201381.","journal-title":"JAMA Ophthalmol"},{"key":"1286_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/01658107.2024.2419846","volume":"49","author":"S Mori","year":"2024","unstructured":"Mori S, Chihara N, Iwaki Y, Okuda-Arai M, Takano F, Ueda K, et al. Evaluation of brain and spinal cord lesions and cerebrospinal fluid analysis in detecting demyelinating diseases in patients with optic neuritis. Neuroophthalmology. 2024;49:154\u201360.","journal-title":"Neuroophthalmology"},{"key":"1286_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","volume":"111","author":"JL Keltner","year":"1993","unstructured":"Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol. 1993;111:231\u20134.","journal-title":"Arch Ophthalmol"},{"key":"1286_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10384-018-0602-9","volume":"62","author":"S Mori","year":"2018","unstructured":"Mori S, Kurimoto T, Ueda K, Nakamura M. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders. Jpn J Ophthalmol. 2018;62:525\u201330.","journal-title":"Jpn J Ophthalmol"},{"key":"1286_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/01658107.2017.1299766","volume":"41","author":"M Hata","year":"2017","unstructured":"Hata M, Miyamoto K. Causes and prognosis of unilateral and bilateral optic disc swelling. Neuroophthalmology. 2017;41:187\u201391.","journal-title":"Neuroophthalmology"},{"key":"1286_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110592","volume":"9","author":"Y Matsui","year":"2014","unstructured":"Matsui Y, Matsubara H, Ueno S, Ito Y, Terasaki H, Kondo M. Changes in outer retinal microstructures during six month period in eyes with acute zonal occult outer retinopathy-complex. PLoS ONE. 2014;9:e110592.","journal-title":"PLoS ONE"},{"key":"1286_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s40135-021-00276-y","volume":"9","author":"L Roisman","year":"2021","unstructured":"Roisman L, Rossetto JD, Goldhardt R. Autoimmune retinopathy, testing, and its controversies. Curr Ophthalmol Rep. 2021;9:178\u201383.","journal-title":"Curr Ophthalmol Rep"},{"key":"1286_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/eye.2014.144","volume":"29","author":"NR Miller","year":"2015","unstructured":"Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye. 2015;29:65\u201379.","journal-title":"Eye"},{"key":"1286_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2377-10-45","volume":"10","author":"H Nakajima","year":"2010","unstructured":"Nakajima H, Hosokawa T, Sugino M, Kimura F, Sugasawa J, Hanafusa T, et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol. 2010;10:45.","journal-title":"BMC Neurol"},{"key":"1286_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99:307\u201314.","journal-title":"J Neurooncol"},{"key":"1286_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/WNO.0000000000001310","volume":"41","author":"MA Bouffard","year":"2021","unstructured":"Bouffard MA, Mallery RM, Liao YJ, Torun N. Variation in evolving optic neuritis. J Neuroophthalmol. 2021;41:476\u20139.","journal-title":"J Neuroophthalmol"},{"key":"1286_CR20","first-page":"304","volume":"7","author":"S Gotecha","year":"2022","unstructured":"Gotecha S, Kotecha M, Punia P, Chugh A, Shetty V. Neuro-ophthalmic manifestations of intracranial space occupying lesions in adults. Beyoglu Eye J. 2022;7:304\u201312.","journal-title":"Beyoglu Eye J"},{"key":"1286_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jocn.2014.01.005","volume":"21","author":"S Ogra","year":"2014","unstructured":"Ogra S, Nichols AD, Stylli S, Kaye AH, Savino PJ, Danesh-Meyer HV. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. J Clin Neurosci. 2014;21:735\u201340.","journal-title":"J Clin Neurosci"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01286-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:39:59Z","timestamp":1776490799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01286-0","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Mori, None; K. Ueda, None; M. Sakamoto, None; Y. Y-Nakanishi, None; W. Matsumiya, None; A. Miki, None; H. Imai, None; S. Kusuhara, None; M. Nakamura, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}